Pregled bibliografske jedinice broj: 1032910
Dermatopharmacokinetic properties of different topical diclofenac formulations
Dermatopharmacokinetic properties of different topical diclofenac formulations // 1. hrvatski kongres dermatofarmacije s međunarodnim sudjelovanjem: knjiga sažetaka
Zagreb, 2018. str. 62-63 (predavanje, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 1032910 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Dermatopharmacokinetic properties of different topical diclofenac formulations
Autori
Leskur, Dario ; Šešelja Perišin, Ana ; Bukić, Josipa ; Rušić, Doris ; Petrić, Ana ; Petrić, Ivana ; Zekan, Lovre ; Puizina-Ivić, Neira ; Modun, Darko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
1. hrvatski kongres dermatofarmacije s međunarodnim sudjelovanjem: knjiga sažetaka
/ - Zagreb, 2018, 62-63
Skup
1. hrvatski kongres dermatofarmacije = 1st Croatian Congress on Dermatopharmacy
Mjesto i datum
Zagreb, Hrvatska, 23.03.2018. - 24.03.2018
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Domaća recenzija
Ključne riječi
diclofenac ; dermatopharmacokinetic properties ; in vitro permeation
Sažetak
Purpose of the work: Standard pharmacokinetic testing of drugs applied topically on the skin is usually focused on potential systemic absorption and involves measuring drug concentration in blood followed by calculation of its systemic bioavailability. However, skin itself is a pharmacokinetic compartment that requires further attention and the importance of dermatopharmacokinetic testing of different topical formulations has been often underlined. The aim of this study was to determine dermatopharmacokinetic properties of different topical diclofenac formulations, by combining experiments with human participants and in vitro laboratory testing. Materials and methods: Two diclofenac gels with considerably different constituents (product A and product B) were applied to volar forearms of the participants (n=5) in amount of io mg of formulation per cm2 of the skin. Test sites were stripped, using sampling discs, 3, 6 and 23 hours after application. First disc on each site was discarded after stripping while next 15 consecutive discs were analysed for the protein content. Diclofenac was extracted from the discs with methanol and its content was measured using HPLC instrumentation. The measured diclofenac level was standardised to the mass of stratum corneum proteins removed by stripping. Two formulations were also tested in vitro, by using Franz cell for permeation test study. Results: The level of diclofenac after application of product A was higher in comparison to product B after 3, 6 and 23 hours (0.67±0.13 vs. 0.51±0.10, 0.50±0.12 vs. 0.37±0.46, 0.20±0.03 vs. 0.15±0.02 ug/ug/cm2, respectively, data are presented as mean±SEM). Area under curve T3-23 h was similarly higher for product A (7.67±1.6 vs. 5.75±0.44 ug*h/ug/cm2), and the flux was different as well (0.0046±0.0015 vs. 0.0034±0.0008 hr-1). However, some of this observed differences lacked reaching statistical significance. Similar results were obtained by in vitro permeation test study. Conclusions: Results of the pilot study suggest the difference in dermatopharmacokinetic properties of the two tested diclofenac formulations might exist. Further studies with higher number of participants are warranted to confirm this difference.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split
Profili:
Ana Šešelja Perišin
(autor)
Dario Leskur
(autor)
Lovre Zekan
(autor)
Josipa Bukić
(autor)
Doris Rušić
(autor)